Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP905261.RA9fAJ3PHGCZYOktX1GE1LCoY9DWJk9TLHCSkFKVp2teE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP905261.RA9fAJ3PHGCZYOktX1GE1LCoY9DWJk9TLHCSkFKVp2teE130_assertion type Assertion NP905261.RA9fAJ3PHGCZYOktX1GE1LCoY9DWJk9TLHCSkFKVp2teE130_head.
- NP905261.RA9fAJ3PHGCZYOktX1GE1LCoY9DWJk9TLHCSkFKVp2teE130_assertion description "[There was an insignificant trend toward loss of BLU methylation with advancing clinical stages of SCC (84.8%, 67.7%, and 63.6% in stages I, II, and III/IV, respectively; P=0.08).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905261.RA9fAJ3PHGCZYOktX1GE1LCoY9DWJk9TLHCSkFKVp2teE130_provenance.
- NP905261.RA9fAJ3PHGCZYOktX1GE1LCoY9DWJk9TLHCSkFKVp2teE130_assertion evidence source_evidence_literature NP905261.RA9fAJ3PHGCZYOktX1GE1LCoY9DWJk9TLHCSkFKVp2teE130_provenance.
- NP905261.RA9fAJ3PHGCZYOktX1GE1LCoY9DWJk9TLHCSkFKVp2teE130_assertion SIO_000772 17097722 NP905261.RA9fAJ3PHGCZYOktX1GE1LCoY9DWJk9TLHCSkFKVp2teE130_provenance.
- NP905261.RA9fAJ3PHGCZYOktX1GE1LCoY9DWJk9TLHCSkFKVp2teE130_assertion wasDerivedFrom befree-20150227 NP905261.RA9fAJ3PHGCZYOktX1GE1LCoY9DWJk9TLHCSkFKVp2teE130_provenance.
- NP905261.RA9fAJ3PHGCZYOktX1GE1LCoY9DWJk9TLHCSkFKVp2teE130_assertion wasGeneratedBy ECO_0000203 NP905261.RA9fAJ3PHGCZYOktX1GE1LCoY9DWJk9TLHCSkFKVp2teE130_provenance.